Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...
Quick Summary Looking to build high-quality mobile applications faster and more efficiently? Discover the top 7 mobile app development tools for software developers in 2025 that support cross-platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback